US cardiology market price
2023
US $16.67 billion
2030
US $25.60 billion
CAGR (compound annual growth rate)
6.32%
(2024-2030)
Cardiovascular disease (CVD)
#1 reason for death in the U.S.
Market increasers
Upward growth in cardiovascular sickness due to:
- Weight problems
- High blood pressure
- Diabetes
Technology advancements
Minimally invasive methods
Imagining techniques
Material advancements
Wearables
Remote monitoring
Benefits of technology advancements
Enhance patient results
Lessen healing times
Increase efficiency of cardiovascular treatments
Technology used ranges from echocardiography machines and stress tests to catheterization labs.
Key players in the cardiovascular market
Abbott Laboratories
Boston Scientific Corp.
Edwards Lifesciences
Cardinal Health Inc.
Medtronic PLC
GE Healthcare
Johnson & Johnson Services, Inc.
Siemens Healthcare GmbH
https://www.researchandmarkets.com/report/united-states-cardiovascular-devices-market
ICONS: ADOBE STOCK
Explore the May 2024 Issue
Check out more from this issue and find your next story to read.
Latest from Today's Medical Developments
- Syringe-less injector system for diagnostic imaging obtains fourth FDA clearance
- Hohenstein Medical debuts enhanced medical device testing capabilities
- Arterex unveils unified brand identity
- Dymax demonstrates light-curing material solutions for medical devices
- Able Medical Devices showcases latest sternal closure solutions
- TMTS 2026 explores AI-powered sustainable manufacturing and more
- QT9 QMS platform streamlines quality management, compliance for medical device manufacturers
- Spineology releases patient-specific expandable spinal implant
